Fecal microbiota transplantation may improve symptoms of irritable bowel syndrome

News Hour:

Fecal microbiota transplantation may improve symptoms of irritable bowel syndrome (IBS), according to a study in the Lancet Gastroenterology and Hepatology.

Roughly 90 patients with moderate-to-severe, diarrhea-predominant IBS and abdominal pain at least weekly were randomized to receive either a fresh or frozen fecal microbiota transplantation from donor stool or a placebo transplant (their own frozen stool) via colonoscopy.

The primary outcome — symptom relief 3 months after transplantation — significantly favored active transplantation over placebo (65% vs. 43% of participants). A commentator says that five patients would need to be treated for one patient to see significant symptom relief. However, the between-group difference was no longer significant after 12 months.

The commentator cautions that the primary outcome “was not one that would be accepted” by regulatory agencies. In addition, whether the treatment affected patients’ fecal microbiota is not reported.


This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Join Epidemiology Congress 2019

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Sacred Games exposes Rajshri Deshpande nude [video]
Anurag Kashyap shoots Kubra Saith 7 times nude and made her cry for frontal nudity scene [Video]
New Viber feature lets you create your own custom stickers
SINGER Furniture offers up to 60% discount in Bangladesh
Chinese, Russian visitor surge push Dubai toward 20 million target
Daewoo to conduct 3D survey in Bay of Bengal to explore gas


News of the Month

November 2017
« Oct   Dec »
Scroll Up
%d bloggers like this: